BPC-157 is most often considered when: Recovery from a musculoskeletal injury has stalled beyond the expected timeline Inflammation appears to be a persistent driver rather than an acute protective response Gut lining integrity is a concern as part of a broader inflammatory or digestive picture The patient is a reasonable candidate for physician-supervised peptide therapy based on health history and risk profile It is not appropriate when there is an unresolved structural question that imaging should answer first, when there are acute red flag symptoms warranting urgent evaluation, or when the individual is hoping a peptide will substitute for rehabilitation and load management
Tirzepatide: A dual GLP-1 and GIP receptor agonist, Tirzepatide not only helps control appetite but also enhances insulin sensitivity and fat metabolism
If the next dose is less than 3 days away, skip the missed dose and resume on schedule
With the ongoing debate over weight-loss drugs, she wrestled with the same doubts others have voiced
Wipe that rubber stopper with alcohol too
The following sections examine representative systemsapelin, spexin, meteorin-like protein (METRNL), and oxyntomodulinwith explicit attention to the evidence supporting their metabolic roles, the reasons for historical underexploration, and the translational questions that remain unresolved